Companies / Viridian Therapeutics, Inc. / Activity
Activity — Viridian Therapeutics, Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Pinnacle Wealth Planning Services, Inc. 13F manager | New | Common stock | $147 | +8 | 8 <0.01% of shares | low |
| Q1 2026 as of | MassMutual Private Wealth & Trust, FSB 13F manager | New | Common stock | $156 | +8 | 8 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $372 | +19 | 19 <0.01% of shares | low |
| Q1 2026 as of | Zions Bancorporation, National Association /Ut 13F manager | New | Common stock | $1.8K | +90 | 90 <0.01% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $176.4K | +6K | 5,670 <0.01% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $248.0K | +13K | 12,680 0.01% of shares | low |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | New | Common stock | $395.3K | +20K | 20,208 0.02% of shares | low |
| Q1 2026 as of | Nomura Holdings Inc 13F manager | New | Common stock | $434.3K | +22K | 22,205 0.02% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | New | Common stock | $686.8K | +35K | 35,114 0.03% of shares | low |
| Q4 2025 as of | Oxford Asset Management LLP 13F manager | New | Common stock | $875.1K | +28K | 28,121 0.02% of shares | low |
| Q4 2025 as of | Norges Bank 13F manager | New | Common stock | $3.82M | +123K | 122,790 0.11% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common stock | $3.97M | +203K | 203,100 0.18% of shares | low |